CD8A and neoplasm: However, efficacies of these treatments are reduced when a fibroblast TGF-β signaling signature is detected, which is especially common in patients with tumors in which CD8+ T cells are excluded from the tumor parenchyma but are found in fibroblast-rich, collagen-rich peritumoral stroma.